Category Archives: Anti-Aging Medicine

New York, United States

The global anti-aging market was valued at USD 149362.8 million in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2024, by value, reaching around USD 274290.1 million by the end of the forecast period. According to the report, North America was the largest contributor in terms of revenue to the global anti-aging market in 2017.

Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=51553

Increase in the aging population is driving the global anti-aging marketIncreasing life expectancy and fall in birth rate are the major causes of an aging population. The aging population develops wrinkles due to lack of nutrients in the body, exposure to UV light, smoking, dehydration, medications and other genetic factors fueling the global anti-aging market.Globally, aging population plays a major role in the growth of the anti-aging market. Old age is associated with loss of fibrous tissue and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, leading to wrinkles, dryness, pigmentary alteration, and sagging of the skin. In addition, anti-aging products and devices help in reducing skin aging, thus giving younger look to a person by revitalizing and tightening the skin leading to the growth of the market

The key driver for the global anti-aging market is growth in anti-aging awareness campaigns. Major aspect of peoples life is engrossed by social media. This campaigns aims to ensure that all medical professionals are aware of the latest scientific research and the recent medical and surgical advances. For instance, EuroMediCom has organized the 4thAMWC Latin America- Aesthetic & Anti-Aging Medicine World Congress from 16th November to 18th November 2017, in Colombia, South America. These conference and seminars, along with social media, are expected to create awareness among students, delegates, and plastic surgeons about advanced anti-aging treatments.

Request Full Report :-https://reportocean.com/industry-verticals/sample-request?report_id=51553

Global Anti-aging Market: Scope of the Report

The global market for anti-aging is segmented by type of product, by type of device, by treatment, demography, and geography. The type of product is further segmented into Anti-Wrinkle, Hair Color, UV Absorbers, Anti-Stretch Marks and Others. The type of device is further segmented into Radiofrequency, Laser, Anti-Cellulite, and Microdermabrasion. Treatment segment is bifurcated as Hair Restoration, Anti-Pigmentation, Anti-Adult Acne, Liposuction, Breast Augmentation, Chemical Peel and Others.

Demography is segmented (Generation X, Baby Boomer, and Generation Y)Geographically, the global anti-aging market is bifurcated into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America anti-aging market was the most prominent market because anti-aging industry is one the major revenue contributor within the manufacturing industries. Thus, the demands for anti-aging products, like Anti-Wrinkle, Hair Color, UV Absorbers and Anti-Stretch Marks will generate higher revenue returns over the forecast period.

Global Anti-aging Market: Competitive DynamicsMajor industry players in global anti-aging market are adopting different strategic initiatives such as mergers and acquisitions, partnerships, and collaborations for strategic expansion in the anti-aging market. For instance, In January 2016, LOreal unveiled My UV Patch, the first-ever stretchable skin sensor designed to monitor UV exposure and help consumers educate themselves about sun protection.

Request Full Report :-https://reportocean.com/industry-verticals/sample-request?report_id=51553

Market Segmentation: Global Anti-aging MarketType of Product, Anti-Wrinkle, Hair Color, UV Absorbers, Anti-Stretch MarksType of Device, Radiofrequency, Laser, Anti-Cellulite, MicrodermabrasionBy Treatment, Hair Restoration, Anti-Pigmentation, Anti-Adult Acne, Liposuction, Breast Augmentation, Chemical Peel, OthersBy Demography, Generation X, Baby Boomer, Generation YBy Region, North America, Europe, Asia Pacific, Latin America, Middle East & Africa

What are the key findings of the report?

This report provides comprehensive information on factors expected to influence the market growth and market share in the future.The report offers the current state of the market and future prospects for various geographical regions.This report provides both qualitative and quantitative information about the competitive landscape of the market.

Access full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=51553

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:Report Ocean:Email:sales@reportocean.comAddress: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 UNITED STATES Tel: +1 888 212 3539 (US TOLL FREE)Website:https://www.reportocean.com/

See more here:
Anti-Aging Market Scope and overview, Growth Study, Future Trends, Demands, and Top Players Data by Forecast to 2030 POSTED IN : PRESS-RELEASE Ripon...

ALBANY, N.Y., April 26, 2022 (GLOBE NEWSWIRE) -- Relentless focus on expanding the portfolio of skincare and anti-aging products have pivoted several lucrative avenues in the health and wellness market. In recent years, especially after the outbreaks of COVID-19 pandemic, the emphasis on wellness has gained strong momentum, spurring industry stakeholders to tap into new revenue streams. The global health and wellness market valuation was pegged at more than US$ 4.1 Trn in 2020, and is projected to exceed US$ 6.94 Trn by 2031.

The growing commercialization of multi-functional personal care products such as for skincare and hand care has propelled revenue possibilities, finds an in-depth TMR study on the health and wellness market. The authors of the study also assert that hand care premiumization is a trend that has picked up enormous pace in emerging markets such as in Asia Pacific. Furthermore, the upsurge in sales of alcohol-based hand sanitizers and skincare products for all demographics has contributed to the rapidly expanding size of the health and wellness market.

Personal care product manufacturers over the years have geared toward adopting eco-friendly packaging materials and sustainable sourcing and manufacturing processes, thus expanding lucrative frontiers in the health and wellness market. Further, in several of the hygiene products, health-promoting ingredients are expanding the avenue for these players.

Request Brochure of Health and Wellness Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=450

Key Findings of Health and Wellness Market Study

Request for Analysis of COVID-19 Impact on Health and Wellness Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=450

Health and Wellness Market: Key Drivers

Get Exclusive PDF Sample Copy of Health and Wellness Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=450

Health and Wellness Market: Regional Growth Dynamics

Health and Wellness Market: Key Players

Some of the key players in the health and wellness market are Healing Holidays (Cleveland Travel Ltd.), BodyHoliday Saint Lucia, Lift Brands, Anytime Fitness LLC, Herbalife Nutrition Ltd., Abbott Laboratories, BioThrive Sciences, Unilever plc., L'Oral S.A., The Este Lauder Companies Inc., and Anti-ageing Facial Tools.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=450

Global Health and Wellness Market: Segmentation

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Sexual Wellness Market: Global health organizations and efforts of voluntary organizations for the betterment of women health in underdeveloped countries are also stoking the demand for sexual wellness products, especially sex toys. These organizations conduct adult health awareness workshops periodically for preventive care.

Wellness Tourism Market: The rising demand for services from the global wellness tourism market can be attributed to rising demand for healthy living, stress reduction, gaining authentic experiences, preventing diseases, and managing and changing poor or toxic lifestyle habits or choices.

Health & Wellness Services Market: Rise in awareness about health and wellness services among employers, increase in health care costs, and surge in incidence of chronic diseases are driving demand for health and wellness services in the corporate segment and increasing investments in corporate wellness programs. These factors are expected to drive the global health & wellness services market during the forecast period.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update -https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey

Transparency Market ResearchState Tower,90 State Street, Suite 700,Albany NY 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comFollow Us: Twitter | LinkedInBlog: https://tmrblog.comBrowse PR - https://www.transparencymarketresearch.com/pressrelease/health-and-wellness-market.htm

Continued here:
Health and Wellness Market to Exceed US$ 6.94 Trn by 2031; Companies Expanding Range of Skincare Products to Capture Steady Revenues, Observes TMR...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced a new cell therapy development program: photoreceptor neural cell (PNC) transplants for the treatment of vision loss due to photoreceptor dysfunction or damage. Similar to the companys recently announced pipeline expansion into auditory neurons for the treatment of hearing loss, Lineage has filed for intellectual property protection covering the composition and methods for generating PNCs. Based on recent in vivo data generated using the companys PNCs, these cells may be capable of forming reconstructed retina with high survivability and neural connectivity to surrounding functional layers. Notably, Lineage has demonstrated feasibility which could support a large-scale method for producing both types of photoreceptors, known as rods and cones.

It is natural that, on the heels of the announcement of our alliance with Roche and Genentech for our RPE cell therapy, a deal worth up to $670 million dollars plus double-digit royalties if certain development, approval, and sales milestones are achieved and other conditions are met, that we also would pursue treatments for vision loss through the other major cell type of the retina, the photoreceptors, stated Brian Culley, Lineages CEO. Our fundamental technology and accumulated know-how give us the opportunity to make many different cell types, and we have demonstrated our ability to create new programs rapidly and efficiently in two distinct areas, expanding our cell therapy pipeline to five separate preclinical and clinical programs, while still maintaining what we believe is an appropriate and responsible rate of investment for a company of our size. This latest program is part of our long-term planning for clinical and commercial success and serves as another example of the capability of our technology platform. We believe our ability to, in just a matter of months, advance from a product concept to generating new intellectual property and manufacturing the desired cell types, is illustrative of the power and efficiency of our platform. We believe the combination of our capital discipline and current balance sheet will support multiple years of further progress, during which we anticipate reaching achievements with each of our clinical and preclinical programs.

Dr. Rami Skaliter, who leads the manufacturing function for Lineage, added, Im exceptionally proud of the teams success at overcoming obstacles related to the limited scale of photoreceptor production. Building upon our experience with other cell lineages, we have developed intellectual property, and filed for patent protections, on a manufacturing process which is compatible with large-scale production of photoreceptors in a closed system, improvements which could enable industrial manufacturing. We believe this accomplishment will provide new opportunities for clinical, and ultimately commercial, production of photoreceptors in areas of large unmet need such as Retinitis Pigmentosa, Stargardts Macular Dystrophy, and retinal detachments, either independently or through strategic alliances.

As part of a scientific collaboration with Professors Benjamin Reubinoff, M.D., Ph.D. and Eyal Banin, M.D., Ph.D., of the Hadassah-Hebrew University Medical Center, the differentiation of pluripotent cells into photoreceptors with clinically compatible characteristics was established utilizing a novel differentiation protocol which generated positive identity of key markers of both rods and cones photoreceptor populations. The data generated by the company further demonstrated that a single cell suspension of photoreceptor precursor cells has the potential to survive and mature post-transplantation in a rodent model of retinal degeneration.

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineages programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineages clinical programs are in markets with billion dollar opportunities and include five allogeneic (off-the-shelf) product candidates: (i) OpRegen, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, which is now being developed under a worldwide collaboration with Roche and Genentech, a member of the Roche Group; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; (iii) VAC2, a dendritic cell therapy produced from Lineages VAC technology platform for immuno-oncology and infectious disease, currently in Phase 1 clinical development for the treatment of non-small cell lung cancer (iv) ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy, and (v) PNC1, a photoreceptor neural cell therapy for the treatment of vision loss due to photoreceptor dysfunction or damage. For more information, please visit http://www.lineagecell.com or follow the company on Twitter @LineageCell.

Forward-Looking Statements

Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as believe, aim, may, will, estimate, continue, anticipate, design, intend, expect, could, can, plan, potential, predict, seek, should, would, contemplate, project, target, tend to, or the negative version of these words and similar expressions. Such statements include, but are not limited to, statements relating to (i) the potential amount of payments to Lineage under the alliance with Hoffman-La Roche Ltd. (Roche) and Genentech, Inc., (ii) the potential for new opportunities for clinical, and ultimately commercial, production of photoreceptors in areas of large unmet need, (iii) Lineages position to become a leader in the emerging field of regenerative medicine and anti-aging technology, and (iv) future areas of potential treatment using PNC transplant. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineages actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, but not limited to, the risk that competing alternative therapies may adversely impact the commercial potential of OpRegen, which could materially adversely affect the payments payable to Lineage under the Roche/Genentech collaboration and license agreement, the risk that Roche/Genentech may not be successful in completing further clinical trials for OpRegen and/or obtaining regulatory approval for OpRegen in any particular jurisdiction; the risk that Lineage might not succeed in developing products and technologies that are useful in medicine and demonstrate the requisite safety and efficacy to achieve regulatory approval in accordance with its projected timing, or at all; the risk that Lineages intellectual property may be insufficient to protect its assets; risks and uncertainties inherent in Lineages business and other risks discussed in Lineages filings with the Securities and Exchange Commission (SEC). Lineages forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading Risk Factors in Lineages periodic reports with the SEC, including Lineages most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the SEC and its other reports, which are available from the SECs website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

See the original post:
Lineage Announces a Fifth Cell Therapy Program: Allogeneic Photoreceptor Transplants for the Treatment of Diseases Which May Lead to Blindness -...

4/21/2022

PITTSBURGH UPMC Childrens Hospital Foundation today announced it has received a $1 million gift from Alba Tull to advance pediatric neuroscience research, education and patient care at UPMC Childrens Hospital of Pittsburghs Childrens Neuroscience Institute (CNI).

The gift builds upon Tulls deep commitment to neurological research, specifically in the greater Pittsburgh area. Last year, she worked with the University of Pittsburgh School of Medicine to create the Alba Tull Center for Neuro Imaging and Therapeutics. The Center is dedicated to designing and expanding imaging technologies for patient care to produce a new, sophisticated understanding of the brain to develop anti-aging therapeutics. Todays gift will now help bring that same commitment of pursuing innovative neuroscience research and treatment to children.

The past few years have truly highlighted that medicine is the backbone of our future, which is why supporting leading research and developments in health care especially for those who are most precious, children is one of my top priorities, said Alba Tull, philanthropist and founder of First Light Capital Group. I continue to be inspired by UPMC Childrens work, especially in neuroscience. I am proud to continue to support and work alongside CNI as they continue to make monumental advancements in their innovative research and new discoveries for pediatric neuroscience.

Tull is a long-time supporter of UPMC Childrens. Her involvement began several years ago with her gift to support research and Creative and Expressive Arts Therapy, and she has long served as a member of UPMC Childrens Foundations Board of Trustees. Her involvement with CNI began last year when she pledged her support for the hospital during its DVE Rocks Childrens Radiothon. After meeting with several neuroscience and research leaders at UPMC Childrens, she decided to designate the donation for CNI.

Todays children are tomorrows future, and we are tremendously grateful for the generous support from Alba Tull, who is advancing our vision to build a premier destination for pediatric neuroscience research, education, and care, said Terence Dermody, M.D., chair of pediatrics at UPMC Childrens. We are thrilled about the research this gift will enable CNI to undertake. Funding for pediatric research, including childrens brain health, is an area of tremendous need. This extraordinary gift will help us fulfill our mission, investing in the science of brain health and disease that will improve the lives of children in Pittsburgh and throughout the world. We are very thankful to Alba Tull for continuing to support the important work of our team and hospital.

The largest donation in CNIs history, the gift will provide flexible research funding to address some of the most pressing priorities of the program, including research infrastructure, pilot grants, and training future leaders, all of which will help generate new breakthroughs in pediatric neuroscience. In particular, it will be used to help progress the understanding of neurological illness, discover and develop personalized therapies for children with neurological diseases or impairments, as well as innovate diagnostic medicine and find ways to translate research directly to patients.

CNI continues to grow and make cutting edge-advancements in the field of neurological disorders. To that end, the research team will continue to prioritize connectivity, neurodevelopment, neonatal and fetal stroke, and lipidomics, a new and quickly growing field of research.

CNI is led by Hlya Bayr, M.D, an award-winning and international leading physician-scientist who has spent decades studying pediatric neurocritical care and traumatic brain injury. With the support from Alba Tull, Bayr will be equipped to bolsters CNIs efforts towards translating innovative research more quickly to patients.

About UPMC Childrens Hospital Foundation

UPMC Childrens Hospital Foundation is the catalyst that unites communities and contributors to create healthier futures for all children through life-changing care and cutting-edge research. As the sole fundraising arm of UPMC Childrens Hospital of Pittsburgh, we support their vision of being the world leader in pediatric health care, education, and discovery. The Foundation is a public charity under 501(c)(3) and 170(b)(1)(A) of the Internal Revenue Service Code. For more information, visit http://www.givetochildrens.org

About Alba Tull

Alba Tull is a leading female philanthropist, accomplished multi-disciplined photographer and film producer, and leading investor. She is the founder and Managing Director of the First Light Capital Group, the technology-informed investment firm and female entrepreneur seeder. She also serves as the chairperson of Tull Investment Group, a privately held investment fund that manages an array of real estate holdings and interest in companies including Genies, Pinterest, Zoox, and Oculus Rift.

Outside of her professional work, Tull is the chair of her familys philanthropic organization, the Tull Family Foundation (TFF), and serves on the board of many leading organizations, including UPMC Childrens Hospital Foundation, the Pittsburghs Carnegie Science Center, The Rett Syndrome Research Trust and The Jackie Robinson Foundation. She is also a member of Carnegie Mellon Universitys Highlands Circle and is a life-long supporter of the United States Navy, where she is currently serving as the sponsor of the next-generation ship, the USS Cooperstown LCS 23.

View post:
UPMC Children's Hospital Foundation Receives $1 Million Gift from Alba Tull to Benefit Children's Neuroscience Institute - UPMC

But experts say there is little scientific evidence backing the treatments. They also caution that medically unnecessary IV drips could be risky for some people particularly those who have heart disease or kidney problems.

For these individuals, getting too much fluid too fast could be harmful because their heart or kidney cant tolerate a lot of salts and fluids being introduced into their bodies, says Sam Torbati, M.D., co-chair of the Department of Emergency Medicine at Cedars-Sinai Medical Center in Los Angeles. Medically speaking, thats where there is the most potential for harm.

He recommends checking with your medical provider before visiting a drip clinic.

An IV can be lifesaving for a patient who is severelydehydrated, nutrient deficient or suffering from a massive infection. But many experts say theres no reason to get what is essentially an invasive treatment unless a doctor recommends it.

IV hydration is a great thing for people who really need it, says Robert H. Shmerling, M.D., senior faculty editor of Harvard Health Publishing, who has researched IV therapy. When it comes to these IVs on demand, the short answer is, Buyer beware. They are expensive and not clearly helpful in any scientific, proven way.

While its true that an IV can hydrate you faster than drinking fluids by mouth, Shmerling says, that doesnt necessarily translate into any kind of health benefit.

Onereview studypublished in the journalSports Healthfound no evidence that IV fluid administered to athletes enhanced performance or helped them rehydrate any better than oral fluids.

If youre able to drink fluids and your digestive system is working thats the best way to get them, Shmerling says.

If youre too sick or elderly to keep up with your bodys need for fluids by drinking, then you should be in a medical facility, he adds.

The claims for IV therapy go beyond simple hydration, however. At most clinics, you can choose from a selection of concoctions, depending on your goal. There are different cocktails to cure a hangover,boost the immune system, improve energy, help with workout recovery, treat jet lag, improve skin, remove toxins and reverse the signs of aging.

There is little evidence to back any of those benefits, Shmerling says, and the clinics are not regulated by the Food and Drug Administration. The marketing has gotten way out ahead of the science.

In fact, most clinics include some variation of this disclaimer on their website and in marketing materials: The services provided have not been evaluated by the Food and Drug Administration. Any designations or references to therapies are for marketing purposes only.

One of the few controlled clinical studies that looked at IV vitamin therapy compared to a placebofound that patients with fibromyalgiareported less tenderness and pain after receiving a specific infusion called a Myers Cocktail, a mix of magnesium, calcium, and vitamins C and B invented by a physician named John Myers.

But heres the catch: Patients in the study who were injected with just saline solution reported the same positive results a sign of a strong placebo effect, the studys authors wrote.

If you decide to try IV therapy, make sure youre getting the treatment in a safe, clean environment. Also ask who will be administering your IV and how much experience they have, Torbati advises.

Because you are getting a needle placed in your arm, there is a chance of pain or bruising or, in rare cases, infection or inflammation of the vein. Older patients tend to have smaller veins, so placing an IV in someone over age 65 is more difficult than in a younger person. The more frail and medically complex you are, the more cautious I would be about trying these things, Torbati says.

Its also important to ask exactly what substances will be going into your body.

Some drips have anti-inflammatory or anti-nausea medications that could cause an allergic reaction orinteract with drugs a patient is currently taking, Torbati says. Other infusions include prescription drugs such as ketorolac and lidocaine that could lead to life-threatening adverse effects in some patients, according to a 2014 study published in theJournal of Parenteral and Enteral Nutrition.

In 2018, supermodel Kendall Jenner was hospitalized after a bad reaction to a Myers Cocktail vitamin IV drip, according to news reports.

Although IV drips are low risk for most healthy people, medical experts generally recommend against them mostly because theyre expensive and unnecessary. The cost of a vitamin drip ranges from a $79 first-time special at some clinics to hundreds of dollars for a special cocktail delivered to your home by a mobile provider.

Theres nothing magical about getting vitamins in an IV, Torbati says. If you want extra nutrition,take a vitamin. If you have a headache, take a Motrin. Instead of spending hundreds on an IV, you can spend a nickel on a pill and get the same benefit.

Michelle Crouch is a contributing writer who has covered health and personal finance for some of the nations top consumer publications. Her work has appeared inReaders Digest,Real Simple,Prevention,The Washington PostandThe New York Times.

Read the original:
The Truth Behind Trendy IV Vitamin Therapy - AARP

Traditional Chinese Herbal Medicine for Face-care Market: Introduction

According to the report, thetraditional Chinese herbal medicine for face-care marketin Asia Pacific was valued at US$569.29Mn in 2020 and is projected to expand at a CAGR of7.1%from 2021 to 2031. Traditional Chinese Herbal Medicine (TCHM) is part of a larger healing system called Traditional Chinese Medicine. Herbs are prescribed to restore energy balance to the opposing forces of energy Yin and Yang that run through invisible channels in the body. Rise in entry of pharmaceutical companies and increase in the geriatric population are anticipated to drive the traditional Chinese herbal medicine for face-care market in Asia Pacific.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84584

China held major share of the traditional Chinese herbal medicine for face-care market in Asia Pacific in 2020 due to rise in awareness among people and increase in the geriatric population. The market in India is likely to expand at a high CAGR of 9.1% from 2021 to 2031. Rise in adoption of traditional Chinese herbal medicine for face-care in India and other countries in Southeast Asia is projected to fuel the growth of the market in Asia Pacific from 2021 to 2031.

Others Segment Dominated Global Market

In terms of benefit, the traditional Chinese herbal medicine for face-care market in Asia Pacific has been classified into anti-aging, brightening (whitening), firming, reducing fine lines, anti-oxidation, hydration, sensitive skin (anti-acne, anti-irritation), and others. The others segment dominated the traditional Chinese herbal medicine for face-care market in Asia Pacific in 2020.

Request for Covid-19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=84584

China to Lead Asia Pacific Market; India to Offer Significant Opportunities

In terms of country, the traditional Chinese herbal medicine for face-care market in Asia Pacific has been segmented into China, South Korea, Japan, India, Thailand, Indonesia, and Rest of Asia Pacific. China is anticipated to account for leading share of the traditional Chinese herbal medicine for face-care market in Asia Pacific during the forecast period. The market in India is expected to grow at a rapid pace in the near future.

Growth Strategies of Key Players

Key players operating in the traditional Chinese herbal medicine for face-care market in Asia Pacific are Eu Yan Sang, Integrated Chinese Medicine Holdings Ltd., Shanghai Jahwa United Co., Ltd, Solstice Medicine Company, Inc., The Mentholatum Company (ROHTO Pharmaceutical Co., Ltd.), and Yunnan Baiyao Group Co., Ltd. The traditional Chinese herbal medicine for face-care market in Asia Pacific is fragmented due to the presence of large number of international and local players.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84584

Asia Pacific Traditional Chinese Herbal Medicine for Face-care Market: Segmentation

More Trending Reports by Transparency Market Research:

Hyaluronic Acid Products Market: Hyaluronic acid supplements are highly useful for people suffering from orthopedic disorders, such as osteoarthritis a type of degenerative joint disease caused by wear and tear on the joints over time. Hyaluronic acid could also be injected directly into the joints in order to gain pain relief. The hyaluronic acid market primarily thrives on the aging population who are highly susceptible to bone injuries, incontinence, and fractures.

Point-of-Care Diagnostics Market: According to the report, the globalpoint-of-care diagnostics marketwas valued at US$34.1Bn in 2020 and is projected to expand at a CAGR of4.7%from 2021 to 2028. Point-of-care diagnostic test is carried out close to or near the patient location for analysis of health condition as well as presence of infectious diseases.

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information.Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Upfor a 7 day free trial!

Contact Us

Rohit BhiseyTransparency Market Research,90 State Street, Suite 700,Albany, NY 12207Tel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Email: [emailprotected]Website:https://www.transparencymarketresearch.com/

View post:
Traditional Chinese Herbal Medicine For Face-Care Market To Surpass Valuation Of US$ 1.1 Bn By 2031, Increase in Generic Population to Drive the...